Cloning pets goes commercial in US
A California company which cloned the world’s first cat nearly three years ago is starting to fill orders for cloned pets. Genetic Savings and Clone recently produced Bengal kittens Tabouli and Baba Ganoush. Now five customers are paying US$50,000 each for a clone of their cats, which should be ready by December. And several hundred clients are paying $150 a year plus an initial $900 to preserve tissue for future cloning. Critics say that the company is exposing animals to risks without any benefits. “The quest for immortality in ourselves and even in our pets opens the door to commercial interests who want to make a profit on it,” says David Magnus, a Stanford bioethicist. However, the company is offering customers their money back or a new clone if their cloned pet has any defects.
- Prescribe morning-after pills to young teenagers, say US pediatric group - November 30, 2012
- Bahrain sentences protest docs to prison - November 28, 2012
- Terry Pratchett assisted suicide documentary wins International Emmy - November 27, 2012
More Stories
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...